Abstract
Premature ovarian failure is a major risk factor for sexual dysfunction in women who receive treatment for premenopausal breast cancer. Women should be counseled on prevention of vulvovaginal dryness and atrophy when chemotherapy is initiated.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 2230-2232 |
| Number of pages | 3 |
| Journal | Cancer |
| Volume | 120 |
| Issue number | 15 |
| DOIs | |
| State | Published - Aug 1 2014 |
ASJC Scopus subject areas
- Oncology
- Cancer Research